blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2207565

EP2207565 - IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.02.2016
Database last updated on 03.09.2024
Most recent event   Tooltip26.02.2016No opposition filed within time limitpublished on 30.03.2016  [2016/13]
Applicant(s)For all designated states
Janssen Sciences Ireland UC
Eastgate Village, Eastgate
Little Island, County Cork / IE
For all designated states
Wyeth LLC
235 East 42nd Street
New York, NY 10017 / US
[2015/17]
Former [2014/33]For all designated states
Janssen Alzheimer Immunotherapy
Airton Road
Tallaght
Dublin 24 / IE
For all designated states
Wyeth LLC
235 East 42nd Street
New York, NY 10017 / US
Former [2014/16]For all designated states
Janssen Alzheimer Immunotherapy
Little Island Industrial Estate
Little Island, County Cork / IE
For all designated states
Wyeth LLC
235 East 42nd Street
New York, NY 10017 / US
Former [2010/29]For all designated states
Janssen Alzheimer Immunotherapy
Little Island Industrial Estate
Little Island, County Cork / IE
For all designated states
Wyeth LLC
Five Giralda Farms
Madison, NJ 07940 / US
Inventor(s)01 / BLACK, Ronald
2164 Fox Creek Road
Berwyn, PA 19312 / US
02 / EKMAN, Lars
213 Avenida Cortez
La Jolla, CA 92037 / US
03 / LIEBERBURG, Ivan
85 Hillcrest Road
Berkeley, CA 94705 / US
04 / GRUNDMAN, Michael
13236 Haxton Place
San Diego, CA 92130 / US
05 / CALLAWAY, James
4893 Drakewood Terrace
San Diego, CA 92130 / US
06 / GREGG, Keith M.
17719 W. Wind Song Avenue
Goodyear, AZ 85338 / US
07 / JACOBSEN, Jack Steven
229 Mulberry Road
Apt 6
Ramsey, NJ 07446 / US
08 / GILL, Davinder
20 Charlotte Drive
Andover, MA 01810 / US
09 / TCHISTIAKOVA, Lioudmila
19 Abbot Bridge Drive
Andover, MA 01810 / US
10 / WIDOM, Angela
19 Cherokee Road
Acton, MA 01720 / US
 [2014/40]
Former [2010/29]01 / BLACK, Ronald
2164 Fox Creek Road
Berwyn Pennsylvania 19312 / US
02 / EKMAN, Lars
213 Avenida Cortez
La Jolla California 92037 / US
03 / LIEBERBURG, Ivan
85 Hillcrest Road
Berkeley California 94705 / US
04 / GRUNDMAN, Michael
13236 Haxton Place
San Diego California 92130 / US
05 / CALLAWAY, James
4893 Drakewood Terrace
San Diego California 92130 / US
06 / GREGG, Keith M.
17719 W. Wind Song Avenue
Goodyear Arizona 85338 / US
07 / JACOBSEN, Jack Steven
229 Mulberry Road Apt 6
Ramsey New Jersey 07446 / US
08 / GILL, Davinder
20 Charlotte Drive
Andover Massachusetts 01810 / US
09 / TCHISTIAKOVA, Lioudmila
19 Abbot Bridge Drive
Andover Massachusetts 01810 / US
10 / WIDOM, Angela
19 Cherokee Road
Acton Massachusetts 01720 / US
Representative(s)Goodfellow, Hugh Robin
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2015/17]
Former [2010/29]Goodfellow, Hugh Robin
Carpmaels & Ransford 43-45 Bloomsbury Square London
WC1A 2RA / GB
Application number, filing date08839961.317.10.2008
[2010/29]
WO2008US80382
Priority number, dateUS20070999423P17.10.2007         Original published format: US 999423 P
US20080083827P25.07.2008         Original published format: US 83827 P
[2010/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009052439
Date:23.04.2009
Language:EN
[2009/17]
Type: A2 Application without search report 
No.:EP2207565
Date:21.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 23.04.2009 takes the place of the publication of the European patent application.
[2010/29]
Type: B1 Patent specification 
No.:EP2207565
Date:22.04.2015
Language:EN
[2015/17]
Search report(s)International search report - published on:US04.06.2009
(Supplementary) European search report - dispatched on:EP29.03.2012
ClassificationIPC:C07K16/18, A61K39/00, C07K16/28
[2012/18]
CPC:
C07K16/18 (EP,CN,US); A61P25/00 (EP); A61P25/28 (EP);
A61P7/10 (EP); A61P9/00 (EP); C07K16/2896 (EP,US);
G06Q99/00 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,CN,US);
C07K2317/34 (EP,CN,US); C07K2317/56 (EP,CN,US); C07K2317/71 (EP,CN,US);
C07K2317/732 (EP,CN,US); C07K2317/734 (EP,CN,US); C07K2317/77 (EP,CN,US) (-)
Former IPC [2010/29]A61K39/00, C07K16/18
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/17]
Former [2010/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL28.04.2010
BA28.04.2010
MK28.04.2010
RS28.04.2010
TitleGerman:AUF APOE-STATUS BASIERENDE IMMUNTHERAPIEDOSIERUNGEN[2010/29]
English:IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS[2010/29]
French:RÉGIMES IMMUNOTHÉRAPEUTIQUES DÉPENDANT DU STATUT DE L'APOE[2010/29]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase28.04.2010National basic fee paid 
28.04.2010Search fee paid 
28.04.2010Designation fee(s) paid 
28.04.2010Examination fee paid 
Examination procedure28.04.2010Examination requested  [2010/29]
24.10.2012Amendment by applicant (claims and/or description)
06.02.2013Despatch of a communication from the examining division (Time limit: M04)
17.06.2013Reply to a communication from the examining division
04.09.2014Communication of intention to grant the patent
14.01.2015Fee for grant paid
14.01.2015Fee for publishing/printing paid
14.01.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15161872.5  / EP2952524
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.02.2013
Opposition(s)25.01.2016No opposition filed within time limit [2016/13]
Fees paidRenewal fee
12.10.2010Renewal fee patent year 03
11.10.2011Renewal fee patent year 04
11.10.2012Renewal fee patent year 05
14.10.2013Renewal fee patent year 06
14.10.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US5624821  (WINTER GREGORY P [GB], et al) [Y] 1-12 * claims, in particular claim 4 table 1 *;
 [Y]WO2006031653  (WYETH CORP [US], et al) [Y] 1-12 * figure 26B; example 5; sequence 88 *;
 [Y]WO2006083689  (NEURALAB LTD, et al) [Y] 1-12 * page 1 - page 2; sequences 1,2 *;
 [A]  - CHALMERS ET AL, "APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.", NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, (20030601), vol. 29, no. 3, ISSN 0305-1846, pages 231 - 238, XP055020648 [A] 1-12 * page 232, column left * * reference 5 *

DOI:   http://dx.doi.org/10.1046/j.1365-2990.2003.00457.x
International search[A]US2006193850  (WARNE NICHOLAS W [US], et al);
 [X]US2006280743  (BASI GURIQ [US], et al);
 [Y]US2007196375  (TOBINICK EDWARD L [US]);
 [Y]  - KINNECOM ET AL., "Course of cerebral amyloid angiopathy?related inflammation.", NEUROLOGY., (200704), vol. 68, no. 17, pages 1411 - 1416, XP008132668

DOI:   http://dx.doi.org/10.1212/01.wnl.0000260066.98681.2e
 [A]  - AYLWARD ET AL., "Cerebellar volume in adults with Down syndrome.", ARCH NEUROL., (199702), vol. 54, no. 2, pages 209 - 212, XP008132674
 [A]  - KOFKE ET AL., "Remifentanil-Induced Cerebral Blood Flow Effects in Normal Humans: Dose and ApoE Genotype.", NEUROSURG ANESTHES NEUROSCI., (200707), vol. 105, no. 1, pages 167 - 175, XP008132669

DOI:   http://dx.doi.org/10.1213/01.ane.0000266490.64814.ff
by applicantEP0307434
 EP0367166
 WO9007861
 EP0394827
 WO9110741
 US5112946
 WO9213069
 WO9312227
 US5225539
 US5336603
 US5349053
 US5359046
 US5447851
 US5530101
 US5545806
 US5569825
 US5585089
 US5612486
 US5622929
 US5624821
 US5625126
 US5633425
 US5661016
 US5693762
 US5693761
 US5723125
 US5770429
 US5783181
 US5789650
 US5814318
 US5844095
 US5874299
 US5877397
 US5908626
 WO0246237
 WO02088306
 WO02088307
 US2003157579
 US2003165496
 US6624821
 US2004025363
 US2004038304
 US2004038317
 US2004087777
 US6750324
 US2004132066
 WO2004072266
 WO2004080419
 EP1481008
 US2005008625
 US2005090648
 US2005130266
 US2005142131
 WO2005065348
 WO2005069970
 US2005255552
 WO2006003291
 WO2006034653
 WO2006036291
 WO2006055778
 US2006134098
 US2006160184
 WO2006083689
 US2006193850
 US2006198851
 WO2006118959
 US2007020685
 US7318923
 US7335478
 US7365168
 US2008145373
    - SELKOE, TINS, (1993), vol. 16, page 403
    - SELKOE, J. NEUROPATHOL. EXP. NEUROL., (1994), vol. 53, page 438
    - DUFF ET AL., NATURE, (1995), vol. 373, page 476
    - GAMES ET AL., NATURE, (1995), vol. 373, page 523
    - GOATE ET AL., NATURE, (1991), vol. 349, page 704
    - CHARTIER HARLAN ET AL., NATURE, (1991), vol. 353, page 844
    - MURRELL ET AL., SCIENCE, (1991), vol. 254, page 97
    - MULLAN ET AL., NATURE GENET., (1992), vol. 1, page 345
    - HARDY, TINS, (1997), vol. 20, page 154
    - SONGSIVILAI; LACHMANN, CLIN. EXP. IMMUNOL., (1990), vol. 79, pages 315 - 321
    - KOSTELNY ET AL., J. IMMUNOL., (1992), vol. 148, pages 1547 - 1553
    - Epitope Mapping Protocols in Methods in Molecular Biology, (1996), vol. 66
    - STAHLI ET AL., METHODS IN ENZYMOLOGY, (1983), vol. 9, page 242
    - KIRKLAND ET AL., J. IMMUNOL., (1986), vol. 137, page 3614
    - MOREL ET AL., MOL. IMMUNOL., (1988), vol. 25, no. 1, page 7
    - CHEUNG ET AL., VIROLOGY, (1990), vol. 176, page 546
    - MOLDENHAUER ET AL., SCAND. J. IMMUNOL., (1990), vol. 32, page 77
    - HARDY ET AL., TINS, (1997), vol. 20, pages 155 - 158
    - RAVETCH; KINET, ANNU. REV. IMMUNOL, (1991), vol. 9, pages 457 - 92
    - CAPEL ET AL., IMMUNOMETHODS, (1994), vol. 4, pages 25 - 34
    - DE HAAS ET AL., J. LAB. CLIN. MED., (1995), vol. 126, pages 330 - 41
    - GENOMICS, (1988), vol. 3, pages 373 - 379
    - J. BIOL. CHEM., (1984), vol. 259, pages 5495 - 5499
    - PROC. NATL. ACAD. SCI. U.S.A., (1985), vol. 82, pages 3445 - 3449
    - CORDER, SCIENCE, (1993), vol. 261, pages 921 - 3
    - FARRER, JAMA, (1997), vol. 278, pages 1349 - 56
    - SAUNDERS, NEUROLOGY, (1993), vol. 43, pages 1467 - 72
    - PEDIATRIC NEUROLOGY, vol. 20, no. 3, pages 241 - 243
    - AJNR, vol. 26, pages 825 - 830
    - NEJM, vol. 334, no. 8, pages 494 - 500
    - PEDIATR NEPHROL, vol. 18, pages 1161 - 1166
    - INTERNAL MEDICINE JOURNAL, vol. 35, pages 83 - 90
    - JNNP, vol. 68, pages 790 - 791
    - AJNR, vol. 23, pages 1038 - 1048
    - PAKJ MED SCI, vol. 21, no. 2, pages 149 - 154
    - AJNR, vol. 21, pages 1199 - 1209
    - QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 10029 - 10033
    - NATURE, (1994), vol. 148, pages 1547 - 1553
    - NATURE BIOTECHNOLOGY, (1996), vol. 14, page 826
    - BLECK, BIOPROCESSING JOURNAL, (200509), vol. 1
    - RAVETCH; KINET, ANNU. REV. IMMUNOL., (1991), vol. 9, page 457
    - PARREN ET AL., J. IMMUNOL., (1992), vol. 148, page 695
    - J IMMUNOGEN, (1976), vol. 3, pages 357 - 362
    - LOGHEM, MONOGR ALLERGY, (1986), vol. 19, pages 40 - 51
    - CUNNINGHAM ET AL., J. BIOL. CHEM., (1970), vol. 9, page 3161
    - LANGER, SCIENCE, (1990), vol. 249, page 1527
    - HANES, ADVANCED DRUG DELIVERY REVIEWS, (1997), vol. 28, page 97
    - HSIAO ET AL., SCIENCE, (1996), vol. 274, page 99
    - STAUFENBIEL ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 13287 - 13292
    - STURCHLER-PIERRAT ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 13287 - 13292
    - BORCHELT ET AL., NEURON, (1997), vol. 19, pages 939 - 945
    - RICHARDS ET AL., J. NEUROSCI., (2003), vol. 23, pages 8989 - 9003
    - CHENG, NAT MED., (2004), vol. 10, no. 11, pages 1190 - 2
    - TAKEUCHI ET AL., AMERICAN JOURNAL OF PATHOLOGY, (2000), vol. 157, pages 331 - 339
    - LAFERLA, NEURON, (2003), vol. 39, pages 409 - 421
    - FANSELOW, ANIM. LEARN. BEHAV., (1990), vol. 18, pages 264 - 270
    - WEHNER ET AL., NATURE GENET., (1997), vol. 17, pages 331 - 334
    - CALDARONE ET AL., NATURE GENET., (1997), vol. 17, pages 335 - 337
    - MANSOURI ET AL., INFECT. IMMUN., (1999), vol. 67, page 1461
    - GELINAS ET AL., AM J OCCUP THER, (1999), vol. 53, pages 471 - 81
    - ROSEN ET AL., AM J PSYCHIATRY, (1984), vol. 141, pages 1356 - 64
    - MCKHANN ET AL., NEUROLOGY, (1984), vol. 34, pages 939 - 44
    - FOLSTEIN ET AL., J PSYCH RES, (1975), vol. 12, pages 189 - 198
    - MORRIS, NEUROLOGY, (1993), vol. 43, pages 2412 - 2414
    - ROSEN ET AL., ANN NEUROL., (1980), vol. 17, pages 486 - 488
    - IDUSOGIE ET AL., J. IMMUNOL., (2000), vol. 164, pages 4178 - 4184
    - PHILLIPS ET AL., CANCER RES., (2000), vol. 60, pages 6977 - 84
    - APRILE ET AL., CLIN. EXP. IMMUNOL., (1981), vol. 46, pages 565 - 76
 WO2005US45614
 WO2007US09499
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.